These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23158254)

  • 1. Intramucosal esophageal adenocarcinoma: primum non nocere.
    Li Z; Rice TW; Liu X; Goldblum JR; Williams SJ; Rybicki LA; Murthy SC; Mason DP; Raymond DP; Blackstone EH
    J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1519-24, 1524.e1-3. PubMed ID: 23158254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
    Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
    Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
    Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
    Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma.
    Zehetner J; DeMeester SR; Hagen JA; Ayazi S; Augustin F; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):39-47. PubMed ID: 21055772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
    Lewis JT; Wang KK; Abraham SC
    Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
    Abraham SC; Krasinskas AM; Correa AM; Hofstetter WL; Ajani JA; Swisher SG; Wu TT
    Am J Surg Pathol; 2007 Nov; 31(11):1719-25. PubMed ID: 18059229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
    Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
    Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens.
    Sepesi B; Watson TJ; Zhou D; Polomsky M; Litle VR; Jones CE; Raymond DP; Hu R; Qiu X; Peters JH
    J Am Coll Surg; 2010 Apr; 210(4):418-27. PubMed ID: 20347733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
    Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
    Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophagectomy for clinical high-grade dysplasia.
    Rice TW; Murthy SC; Mason DP; Rybicki LA; Yerian LM; Dumot JA; Rodriguez CP; Blackstone EH
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):113-9. PubMed ID: 21277216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
    Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
    Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and barrett with high-grade dysplasia.
    Peyre CG; DeMeester SR; Rizzetto C; Bansal N; Tang AL; Ayazi S; Leers JM; Lipham JC; Hagen JA; DeMeester TR
    Ann Surg; 2007 Oct; 246(4):665-71; discussion 671-4. PubMed ID: 17893503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal submucosa: the watershed for esophageal cancer.
    Raja S; Rice TW; Goldblum JR; Rybicki LA; Murthy SC; Mason DP; Blackstone EH
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1403-11.e1. PubMed ID: 22093714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia.
    Kim MP; Brown KN; Schwartz MR; Blackmon SH
    Innovations (Phila); 2013; 8(1):17-22. PubMed ID: 23571789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
    Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia.
    Mandal RV; Forcione DG; Brugge WR; Nishioka NS; Mino-Kenudson M; Lauwers GY
    Am J Surg Pathol; 2009 Apr; 33(4):620-5. PubMed ID: 19047893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.
    Liu L; Hofstetter WL; Rashid A; Swisher SG; Correa AM; Ajani JA; Hamilton SR; Wu TT
    Am J Surg Pathol; 2005 Aug; 29(8):1079-85. PubMed ID: 16006804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence.
    Lagarde SM; de Boer JD; ten Kate FJ; Busch OR; Obertop H; van Lanschot JJ
    Ann Surg; 2008 Jan; 247(1):71-6. PubMed ID: 18156925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
    Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
    J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience.
    Wang VS; Hornick JL; Sepulveda JA; Mauer R; Poneros JM
    Gastrointest Endosc; 2009 Apr; 69(4):777-83. PubMed ID: 19136106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.